Both in Pharmaceuticals
Septerna vs Zymeworks
Over the past year SEPN returned +119.5% and ZYME returned +51.5%; their daily moves had a correlation of 0.21.
SEPN +119.5% ZYME +51.5%Growth of $1, one year, split-adjusted
| Metric | SEPN | ZYME |
|---|---|---|
| Price | $44.00 | $28.61 |
| Market cap | $2.05B | $2.06B |
| Today | −2.72% | −0.35% |
| 1 month | +15.6% | +10.2% |
| 6 months | +86.4% | +7.5% |
| Year to date | +57.8% | +8.7% |
| 1 year | +100.5% | +47.6% |
| Revenue growth (YoY) | +22375.6% | −90.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −48.7% | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | 20.8× | 55.4× |
| Net cash | $372.3M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 46.5% |
| Short % of float | 12.0% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).